Treating hemoglobinopathies using gene-correction approaches: promises and challenges.

about

β-Thalassemia.A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease.Biomedical applications of gene editing.

P2860

Q38998151-DFA66C0E-8DA3-452D-BC3A-A4FC7E557FA3 Q45874858-5CE7EBCB-06AA-4188-A25D-152E81B5B591 Q48512486-F937830F-1C33-4411-AC42-7036152416C4

P2860

Treating hemoglobinopathies using gene-correction approaches: promises and challenges.

Item

http://www.wikidata.org/entity/Q38868151

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Treating hemoglobinopathies using gene-correction approaches: promises and challenges.

@en

type

Item

label

Treating hemoglobinopathies using gene-correction approaches: promises and challenges.

@en

prefLabel

Treating hemoglobinopathies using gene-correction approaches: promises and challenges.

@en

P1476

Treating hemoglobinopathies using gene-correction approaches: promises and challenges

@en

P2093

Renee N Cottle

http://www.w3.org/2001/XMLSchema#string

P2860

CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes

CRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systems

Toward a code for the interactions of zinc fingers with DNA: selection of randomized fingers displayed on phage

Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain

RNA-guided human genome engineering via Cas9

Multiplex genome engineering using CRISPR/Cas systems

The "beta-like-globin" gene domain in human erythroid cells

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks

Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells

P2888

s00439-016-1696-0

P304

993-1010

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00439-016-1696-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

135

http://www.w3.org/2001/XMLSchema#string

P50

Ciaran M Lee

Gang Bao

P577

2016-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1051343269

http://www.w3.org/2001/XMLSchema#string

P698

27314256

http://www.w3.org/2001/XMLSchema#string

P932

5002253

http://www.w3.org/2001/XMLSchema#string

Treating hemoglobinopathies using gene-correction approaches: promises and challenges.

about

P2860

P2860

Treating hemoglobinopathies using gene-correction approaches: promises and challenges.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932